Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Biguanides Market from 2024 to 2033?
The biguanides market has seen steady growth in recent years. It is projected to grow from $4.79 billion in 2023 to $4.96 billion in 2024, with a CAGR of 3.6%. This growth is attributed to rising demand for oral hypoglycemic drugs, a growing geriatric population, increasing obesity rates, and heightened awareness of diabetes management.
The biguanides market is expected to grow to $5.76 billion by 2028 with a CAGR of 3.8%. Growth factors include the adoption of combination therapies and rising healthcare expenditures. Key trends involve a focus on developing extended-release formulations and expanding applications in oncology.
Claim Your Free Sample of the Global Biguanides Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp
What Key Factors Are Fueling the Growth of the Biguanides Market?
The rise in diabetes is expected to stimulate growth in the biguanides market. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to insufficient insulin production. Factors contributing to this increase include lifestyle changes and genetic predisposition. Biguanides like metformin help manage diabetes by improving insulin sensitivity and reducing glucose production. For instance, the UK Office for Health Improvement & Disparities reported that the percentage of individuals with type 1 diabetes receiving recommended care increased by 22% from March 2022 to March 2023, while type 2 diabetes saw a 21% increase. Therefore, the growing prevalence of diabetes is propelling the biguanides market.
What Are the Major Segments of the Biguanides Market?
1) By Type: Metformin, Phenformin, Other Types
2) By Dosage Form: Tablets, Oral Solutions
3) By Formulation: Immediate Release, Extended Release
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
What New Trends Are Transforming the Biguanides Market?
Companies in the biguanide market are focusing on developing extended-release biguanide drugs to improve patient compliance and efficacy. In August 2023, Dr. Reddy’s Laboratories launched saxagliptin and metformin hydrochloride extended-release drugs, enhancing glycemic control for type 2 diabetes patients.
Order Now for Fast Delivery of Your Biguanides Market Report!
https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report
Which Regions Are Driving Growth in the Biguanides Market?
Asia-Pacific was the largest region in the biguanides market in 2023. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The Biguanides Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biguanides market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Biguanides Market Include
1. Biguanides Market Executive Summary
2. Biguanides Market Segments
3. Biguanides Market Size And Template Market Growth Rate
4. Key Biguanides Market Trends
5. Major Biguanides Market Drivers
……
25. Key Mergers And Acquisitions In The Biguanides Market
26. Top Biguanides Companies
27. Biguanides Market Opportunities And Strategies
28. Biguanides Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Small Molecule API Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/small-molecule-api-global-market-report
Global Softgel Capsules Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/softgel-capsules-global-market-report
Urothelial Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/urothelial-cancer-drugs-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
